Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AMMJ Stock Summary
In the News
AMMJ Financial details
Company Rating
Sell
Market Cap
1.88M
Income
-368.36K
Revenue
13.49M
Book val./share
0.02
Cash/share
0
Dividend
-
Dividend %
-
Employees
24
Optionable
No
Shortable
Yes
Earnings
15 Apr 2024
P/E
-1.61
Forward P/E
-
PEG
0.21
P/S
0.09
P/B
0.43
P/C
-
P/FCF
-1.86
Quick Ratio
0.1
Current Ratio
0.39
Debt / Equity
0.9
LT Debt / Equity
0.54
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-62.63%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-16.74%
Revenue last 5Y
80.48%
Revenue Q/Q
-29.65%
EPS Q/Q
-1900%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-50%
Inst Own
0%
Inst Trans
-0%
ROA
-9%
ROE
-24%
ROC
-0.07%
Gross Margin
18%
Oper. Margin
-1%
Profit Margin
-3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.005-0.087
52W High
-
52W Low
-
RSI
38.99
Rel Volume
0.13
Avg Volume
788.38K
Volume
101.56K
Perf Week
-18.18%
Perf Month
-32.33%
Perf Quarter
-58.33%
Perf Half Y
-65.71%
-
-
-
-
Beta
1.018
-
-
Volatility
0%, 0%
Prev Close
-6.64%
Price
0.009
Change
-5.26%
AMMJ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.02 | 0.04 | 0.03 | 0.03 | 0.22 | |
Net income per share | -0.02 | -0.01 | -0.01 | -0.02 | -0.01 | |
Operating cash flow per share | -0.01 | 0 | -0.01 | -0.01 | 0 | |
Free cash flow per share | -0.01 | 0 | -0.01 | -0.02 | 0 | |
Cash per share | 0.02 | 0.02 | 0.03 | 0.01 | 0 | |
Book value per share | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | |
Tangible book value per share | 0.02 | 0.02 | 0.03 | -0.01 | -0.01 | |
Share holders equity per share | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | |
Interest debt per share | 0 | 0 | 0 | 0.02 | 0.02 | |
Market cap | 15.44M | 5.09M | 4.1M | 5.57M | 2.4M | |
Enterprise value | 14.35M | 4.18M | 2.49M | 6.27M | 3.59M | |
P/E ratio | -16.24 | -9.38 | -6.54 | -3.59 | -3.76 | |
Price to sales ratio | 15.72 | 2.39 | 2.61 | 2.29 | 0.13 | |
POCF ratio | -27.5 | -49.46 | -7.8 | -5.81 | -12.06 | |
PFCF ratio | -27.5 | -35.98 | -7.77 | -4.2 | -7.93 | |
P/B Ratio | 15.36 | 5.78 | 2.52 | 2.63 | 1.28 | |
PTB ratio | 15.36 | 5.78 | 2.52 | 2.63 | 1.28 | |
EV to sales | 14.61 | 1.96 | 1.59 | 2.58 | 0.19 | |
Enterprise value over EBITDA | -24.46 | 27.12 | -4.87 | -5.67 | -11.13 | |
EV to operating cash flow | -25.56 | -40.61 | -4.74 | -6.54 | -18.03 | |
EV to free cash flow | -25.56 | -29.54 | -4.72 | -4.73 | -11.85 | |
Earnings yield | -0.06 | -0.11 | -0.15 | -0.28 | -0.27 | |
Free cash flow yield | -0.04 | -0.03 | -0.13 | -0.24 | -0.13 | |
Debt to equity | 0 | 0.04 | 0.07 | 0.65 | 0.7 | |
Debt to assets | 0 | 0.03 | 0.06 | 0.32 | 0.28 | |
Net debt to EBITDA | 1.85 | -5.91 | 3.15 | -0.63 | -3.68 | |
Current ratio | 4.69 | 3.59 | 7.14 | 0.53 | 0.49 | |
Interest coverage | 13.93K | 0 | -346.66 | -16.4 | -7.69 | |
Income quality | 0.59 | 0.34 | 0.99 | 0.67 | 0.31 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.98 | 0.53 | 0.66 | 0.86 | 0.15 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.65 | 0.55 | |
Capex to operating cash flow | 0 | 0.37 | 0 | 0.38 | 0.52 | |
Capex to revenue | 0 | -0.02 | 0 | -0.15 | -0.01 | |
Capex to depreciation | 0 | -5.9 | -0.16 | -3.83 | -0.46 | |
Stock based compensation to revenue | 0.08 | 0.03 | 0.02 | 0.02 | 0.01 | |
Graham number | 0.09 | 0.06 | 0.08 | 0.11 | 0.06 | |
ROIC | -0.99 | 0.28 | -0.42 | -0.35 | -0.16 | |
Return on tangible assets | -0.75 | -0.45 | -0.33 | -1.04 | -0.31 | |
Graham Net | 0.02 | 0.01 | 0.03 | -0.02 | -0.02 | |
Working capital | 997.28K | 839.55K | 1.6M | -914.62K | -1.08M | |
Tangible asset value | 1.01M | 879.59K | 1.63M | -612.07K | -685.73K | |
Net current asset value | 997.28K | 839.55K | 1.6M | -1.09M | -1.72M | |
Invested capital | 0 | 0.04 | 0.07 | 0.65 | 0.7 | |
Average receivables | 102.84K | 77.27K | 60.31K | 18.14K | 240.21K | |
Average payables | 30.47K | 21.34K | 11.45K | 127.92K | 460.92K | |
Average inventory | 48.38K | 57.16K | 57.86K | 170.51K | 315.79K | |
Days sales outstanding | 21.88 | 16.39 | 5.8 | 1.7 | 9.1 | |
Days payables outstanding | 22.95 | 4.49 | 5.65 | 64.7 | 15.24 | |
Days of inventory on hand | 42.51 | 24.58 | 26.82 | 74.28 | 7.92 | |
Receivables turnover | 16.68 | 22.28 | 62.9 | 214.32 | 40.09 | |
Payables turnover | 15.91 | 81.23 | 64.55 | 5.64 | 23.96 | |
Inventory turnover | 8.59 | 14.85 | 13.61 | 4.91 | 46.1 | |
ROE | -0.95 | -0.62 | -0.39 | -0.73 | -0.34 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.02 | 0.12 | 0.01 | 0.01 | 0.01 | |
Net income per share | 0 | 0 | -0.01 | 0 | 0 | |
Operating cash flow per share | -0.01 | 0 | 0 | 0 | 0 | |
Free cash flow per share | -0.01 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Tangible book value per share | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | |
Share holders equity per share | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Interest debt per share | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Market cap | 3.57M | 2.58M | 1.9M | 1.63M | 2.83M | |
Enterprise value | 4.14M | 3.77M | 3.31M | 2.98M | 4.05M | |
P/E ratio | -3.73 | 2.2 | -0.92 | 34.38 | -4.51 | |
Price to sales ratio | 1.68 | 0.23 | 2.67 | 1.91 | 4.72 | |
POCF ratio | -6.18 | -9.64 | -9.11 | 43.78 | -17.8 | |
PFCF ratio | -5.23 | -9.69 | -7.68 | 43.79 | -17.8 | |
P/B Ratio | 2.84 | 1.38 | 1.28 | 1.09 | 2.07 | |
PTB ratio | 2.84 | 1.38 | 1.28 | 1.09 | 2.07 | |
EV to sales | 1.95 | 0.33 | 4.65 | 3.5 | 6.76 | |
Enterprise value over EBITDA | -9.47 | 5.12 | -8.95 | 28.49 | -58.57 | |
EV to operating cash flow | -7.17 | -14.07 | -15.88 | 80.23 | -25.47 | |
EV to free cash flow | -6.07 | -14.14 | -13.37 | 80.25 | -25.47 | |
Earnings yield | -0.07 | 0.11 | -0.27 | 0.01 | -0.06 | |
Free cash flow yield | -0.19 | -0.1 | -0.13 | 0.02 | -0.06 | |
Debt to equity | 0.61 | 0.7 | 0.99 | 0.97 | 0.9 | |
Debt to assets | 0.18 | 0.28 | 0.33 | 0.33 | 0.29 | |
Net debt to EBITDA | -1.3 | 1.61 | -3.81 | 12.94 | -17.63 | |
Current ratio | 0.32 | 0.49 | 0.39 | 0.45 | 0.39 | |
Interest coverage | -6.18 | -2.81 | -13.93 | -4.05 | 4.51 | |
Income quality | 1.45 | -0.59 | 0.45 | 3.14 | 1.25 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.32 | 0.07 | 0.92 | 0.52 | 0.54 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.62 | 0.55 | 0.57 | 0.55 | 0.58 | |
Capex to operating cash flow | 0.18 | 0 | 0.19 | 0 | 0 | |
Capex to revenue | -0.05 | 0 | -0.05 | 0 | 0 | |
Capex to depreciation | -2.55 | 0.01 | -0.64 | 0 | 0 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0 | |
Graham number | 0.03 | 0.04 | 0.05 | 0.01 | 0.03 | |
ROIC | -0.13 | 0.1 | -0.14 | 0.63 | -0.05 | |
Return on tangible assets | -0.15 | 0.14 | -0.27 | 0.01 | -0.09 | |
Graham Net | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 | |
Working capital | -1.98M | -1.08M | -1.32M | -1.19M | -1.26M | |
Tangible asset value | -1.41M | -685.73K | -1.03M | -969.88K | -1.05M | |
Net current asset value | -2.07M | -1.72M | -2.07M | -1.98M | -2M | |
Invested capital | 0.61 | 0.7 | 0.99 | 0.97 | 0.9 | |
Average receivables | 232.68K | 364.52K | 411.96K | 324.05K | 247.9K | |
Average payables | 481.7K | 566.45K | 736.48K | 801.56K | 872.15K | |
Average inventory | 316.36K | 352.73K | 363.35K | 441.01K | 513.29K | |
Days sales outstanding | 11.02 | 3.73 | 44.82 | 30.96 | 30.38 | |
Days payables outstanding | 21.9 | 6.2 | 163.9 | 149.77 | 239.63 | |
Days of inventory on hand | 17.02 | 3.22 | 77.17 | 94.06 | 132.84 | |
Receivables turnover | 8.17 | 24.13 | 2.01 | 2.91 | 2.96 | |
Payables turnover | 4.11 | 14.5 | 0.55 | 0.6 | 0.38 | |
Inventory turnover | 5.29 | 27.91 | 1.17 | 0.96 | 0.68 | |
ROE | -0.19 | 0.16 | -0.35 | 0.01 | -0.12 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
AMMJ Frequently Asked Questions
What is American Cannabis Company, Inc. stock symbol ?
American Cannabis Company, Inc. is a US stock , located in Denver of Co and trading under the symbol AMMJ
What is American Cannabis Company, Inc. stock quote today ?
American Cannabis Company, Inc. stock price is $0.009 today.
Is American Cannabis Company, Inc. stock public?
Yes, American Cannabis Company, Inc. is a publicly traded company.